News

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Media Contact

Stephen Schultz
VP Investor Relations (U.S.)
T: 917-280-2424 / 401 500 6570
sschultz@gwpharm.com
 

Recent Press Releases

Dec 13, 2008
GW Pharmaceuticals plc (AIM: GWP) welcomes the publication today by the UK regulator, the Medicines & Healthcare products Regulatory Agency (MHRA) of a Public Information Report on Sativex®, GW’s cannabinoid spr
Nov 18, 2008
GW Pharmaceuticals plc (AIM: GWP), the developer and manufacturer of a range of new cannabinoid medicines, including Sativex, announces its preliminary results for the year ended 30 September 2008.
Oct 01, 2008
GW Pharmaceuticals plc (GWP:AIM) announces that it has completed patient recruitment into its Sativex® Phase III MS Spasticity trial.
Jun 19, 2008
GW Pharmaceuticals plc (AIM: GWP), the developer and manufacturer of a range of new cannabinoid medicines, including Sativex®, announces its interim results for the six months ended 31 March 2008.
Jun 05, 2008
GW Pharmaceuticals plc (AIM: GWP) will be announcing its interim financial results for the six months ended 31 March 2008 on Thursday 19 Jun
Apr 08, 2008
GW Pharmaceuticals plc (AIM: GWP) announces preliminary results of a Phase III double-blind randomised placebo-controlled study of Sativex® in 339 patients with central neuropathic pain due to Multiple Sclerosis (MS
Mar 18, 2008
Dr. Geoffrey Guy, Chairman of GW Pharmaceuticals plc, will make the following comments at today’s Annual General Meeting:
Mar 05, 2008
GW Pharmaceuticals plc announces that Adam George BSc, ACA has been appointed as Company Secretary and Financial Controller.
Jan 22, 2008
GW Pharmaceuticals plc (AIM: GWP) announces that it has generated highly promising results in both pre-clinical pharmacology studies and a Phase I trial of a new potential cannabinoid treatment for type 2 diabetes a

Pages